Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (ATRA)

CUSIP: 046513107

Q4 2019 13F Holders as of 31 Dec 2019

Holder snapshot 7 signals
Share change
+2,115,267
Put/Call ratio
238%
SEC-reported price per share
$16.47
Number of holders
112
Value change
+$38,331,911
Number of buys
61
Open additional details 1 more signal available
Number of sells
43
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
9,606,000

Security key

046513107

Report period

Q4 2019

Institutions

112

Top holders

10

Ownership snapshot

Top reported holders of ATRA - Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BAUPOST GROUP LLC/MA
Disclosed value leader
BAUPOST GROUP LLC/MA
Comparable rows
15/15
Latest evidence
30 Sep 2019
13F Lead comparable stake: 86% Showing 1-6 of 15 holder rows.

Quick read

BAUPOST GROUP LLC/MA leads the comparable SEC ownership view at 86%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BAUPOST GROUP LLC/MA's linked filing trail.
Comparable ownership Top 5
BAUPOST GROUP LLC/MA 86%
MAVERICK CAPITAL LTD 53%
Redmile Group, LLC 47%
BlackRock Finance, Inc. 46%
VANGUARD GROUP INC 37%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BAUPOST GROUP LLC/MA
13F
Company
13F
86%
$117,322,000
8,308,900 shares
30 Sep 2019
MAVERICK CAPITAL LTD
13F
Company
13F
53%
$72,068,000
5,103,963 shares
30 Sep 2019
Redmile Group, LLC
13F
Company
13F
47%
$63,818,000
4,519,717 shares
30 Sep 2019
BlackRock Finance, Inc.
13F
Company
13F
46%
$62,815,000
4,448,656 shares
30 Sep 2019
VANGUARD GROUP INC
13F
Company
13F
37%
$50,571,000
3,581,453 shares
30 Sep 2019
MORGAN STANLEY
13F
Company
13F
31%
$41,703,000
2,953,605 shares
30 Sep 2019
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
112
Shares
61,123,347
Rows available
112
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2019 vs Q4 2025 Across Filers

Q4 2025 holders
0
Q4 2019 holders
112
Holder diff
112
Investor Q4 2025 Shares Q4 2019 Shares Share Diff Share Chg % Q4 2025 value Q4 2019 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .